Challenges (ethical and scientific!) and potential solutions to developing drugs that treat rare diseases

For this Case Study Assignment, please review the media pieces posted and answer the following questions about the challenges (ethical and scientific!) and potential solutions to developing drugs that treat rare diseases. Each assignment should be approximately 3 pages in length and will: Outline the Central Problem. After reading each of the provided media pieces, write a paragraph that outlines the central problem or issue posed by the case, supported by specific evidence, events, quotes, etc. from the media pieces as supporting data. This includes a description of the scientific and strategic aspects of the problem. The central problem may not be explicitly stated or thoroughly explained, so you may have to make inferences based on the media pieces to draw conclusions. Ask the Right Questions. After you have identified the central problem outlined by the case, what critical evidence do you need before identifying the potential strategic approaches to solving the problem? What do you want/need to know more about? What questions do you need answered in order to understand the topic further and define potential outcomes? Include a list (yes, an actual list) of 5 thought provoking questions that would further your understanding and drive conversation and insight into this topic. Questions should be well written, higher-order (not simple) questions that show your understanding of the central problem and the contributing factors. Solve the Problem. What are the 2 BEST strategies to approach this problem? What effects would each have on patients? Pharmaceutical companies? What are the potential positive outcomes of each? Shortcomings? Draw a conclusion as to which you think would be most effective and describe why. Take Your Thinking Further. Are these the only approaches? Can you think of other approaches that might help to solve this problem? Research and discuss ONE other innovative approach which would change the current approach to the development of drugs that treat rare diseases. Draw a Conclusion. From the evidence presented in the case, draw a conclusion as to what the best way forward is for the drug pricing, generics and competition in the drug market. Is it the responsibility of pharmaceutical companies to develop and provide affordable drugs? What does ‘affordable’ mean? Describe where you stand on the issue, and be sure to include how this case furthered your understanding of the process of pharmaceutical drug pricing.